Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections.
OBJECTIVE
To examine the impact of prolonged TGF-beta exposure on cartilage and ligamentous joint structures in vivo, to investigate involvement of TGF-beta in osteoarthritis pathology.


METHODS
TGF-beta was injected into murine knee joints once or repeatedly, whereafter articular cartilage proteoglycan (PG) synthesis and content, and histological changes in knee joints were studied over a 2-month period.


RESULTS
A single injection of TGF-beta stimulated patellar cartilage PG synthesis for 3 weeks and PG content for 2 weeks. Triple TGF-beta injections prolonged the increase in PG content to 3 weeks. Patellar cartilage showed no histological abnormalities at 1 and 2 months after the last injection. In contrast, 2 months after triple TGF-beta injections the superficial layer of tibial cartilage still had an increased proteoglycan content, while severe PG depletion was found in deeper layers of the posterior part of the lateral tibia in particular. Eventually, lesions occurred at the level of the tide-mark, exactly the site where cartilage is torn off in experimental and spontaneous osteoarthritis in mice. Additionally, multiple TGF-beta injections induced formation of chondroid structures along the margins of articular cartilage. These chondroid structures were transformed into osteophytes via endochondral ossification. Formation of chondroid tissue was also observed in collateral ligaments.


CONCLUSIONS
Multiple intra-articular injections of TGF-beta induce changes in articular cartilage and surrounding tissues that have strong resemblance to features of experimental and spontaneous osteoarthritis in mice, suggesting a role for TGF-beta in the OA process.
van Beuningen
H M
HM
Department of Rheumatology, University Hospital Nijmegen, Geert Grooteplein Zuid 8, Nijmegen, 6525 GA, The Netherlands.
Glansbeek
H L
HL
van der Kraan
P M
PM
van den Berg
W B
WB
D000818:Animals; D002358:Cartilage, Articular / Q000187:drug effects / Q000378:metabolism; D007270:Injections, Intra-Articular; D007719:Knee Joint; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010003:Osteoarthritis / Q000139:chemically induced* / Q000378:metabolism; D011509:Proteoglycans / Q000378:metabolism; D016212:Transforming Growth Factor beta / Q000009:adverse effects* / Q000378:metabolism
D011509:Proteoglycans; D016212:Transforming Growth Factor beta